Table 7.

Prevention of Secondary Manifestations in Individuals with Arginase Deficiency

Manifestation/
Situation
PreventionConsiderations/Other
Hyperammonemic
episodes
Ongoing education of affected persons & caregivers re natural history, maintenance & emergency treatment, prognosis, & risks of acute encephalopathic crisesWritten protocols for maintenance & emergency treatment should be provided to parents, primary care providers/pediatricians, & teachers & school staff. 1, 2
Treatment protocols & provision of emergency letters or cards to incl guidance for care in the event of illnessEmergency letters/cards should be provided summarizing key information & principles of emergency treatment for arginase deficiency & containing contact information for the primary treating metabolic center.
MedicAlert® bracelets/pendants, or car seat stickers
Adequate supplies of specialized dietary products (protein-free formulas; medication required for maintenance & emergency treatment) should always be maintained at home.For any planned travel or vacations, consider contacting a center of expertise near the destination prior to travel dates.
1.

Essential information including written treatment protocols should be provided before inpatient emergency treatment may be needed.

2.

Parents or local hospitals should immediately inform the designated metabolic center if: (1) temperature is >38.5°C; (2) vomiting/diarrhea or other symptoms of intercurrent illness develop; or (3) new neurologic symptoms occur.

From: Arginase Deficiency

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.